Marie C. Roesch
Ratzeburger Allee 160
Luebeck, SH 23538, Germany
Luebeck, SH 23538, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Comparison of Sex-Specific Treatment Outcomes in Clinical Trials and Subsequent Real-World Data on Systemic Therapies for Urothelial Carcinoma: A Systematic Review.
Journal: Aktuelle Urologie
Published: August 04, 2026
Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients.
Journal: Molecular oncology
Published: February 12, 2026
Three-piece inflatable penile prosthesis implantation in clinical practice
Journal: Urologie (Heidelberg, Germany)
Published: January 26, 2026
Sex distribution in clinical studies in uro-oncology-status quo in Germany
Journal: Urologie (Heidelberg, Germany)
Published: December 19, 2025
A Systematic Review Comparing Sex-Specific Outcomes of Prospective Clinical Trials and Subsequent Real-World Data Focusing on Systemic Treatment Options for Renal Cell Cancer.
Journal: Urologia internationalis
Published: December 03, 2025
Economics, Ergonomics, Effectiveness: A Monocentric Comparison of Single-Use vs. Reusable Flexible Ureteroscopes in Challenging Kidney Stone Cases.
Journal: Aktuelle Urologie
Published: August 06, 2025
Glans necrosis following penile procedures: a systematic review of etiology, frequency, and management.
Journal: International journal of impotence research
Published: February 26, 2025
Gender-/Sex-Specific Differences in Clinical Trials in Uro-Oncology
Journal: Aktuelle Urologie
Published: January 28, 2025
The ductal network in the human testis and epididymis: What belongs to which?
Journal: Clinical anatomy (New York, N.Y.)
Published: August 06, 2024
Therapy sequences and duration in mCRPC: a retrospective review of the Lübeck mCRPC cohort
Journal: Aktuelle Urologie
Published: June 25, 2024
Enfortumab vedotin as a salvage option as 5th line therapy for metastatic urothelial bladder cancer.
Enfortumab vedotin as a salvage option as 5th line therapy for metastatic urothelial bladder cancer.
Journal: Aktuelle Urologie
Published: November 14, 2023
Last Updated: 09/26/2026